Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes

Macrophage migration inhibitory factor (MIF), a widely expressed pleiotropic cytokine, is reportedly involved in several cardiovascular diseases, in addition to inflammatory diseases. Plasma MIF levels are elevated in the early phase of acute cardiac infarction. This study is aimed at investigating...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiyi Yu, Xinyu Wang, Xiangning Deng, Youyi Zhang, Wei Gao
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/8276180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174315788500992
author Haiyi Yu
Xinyu Wang
Xiangning Deng
Youyi Zhang
Wei Gao
author_facet Haiyi Yu
Xinyu Wang
Xiangning Deng
Youyi Zhang
Wei Gao
author_sort Haiyi Yu
collection DOAJ
description Macrophage migration inhibitory factor (MIF), a widely expressed pleiotropic cytokine, is reportedly involved in several cardiovascular diseases, in addition to inflammatory diseases. Plasma MIF levels are elevated in the early phase of acute cardiac infarction. This study is aimed at investigating the correlation between plasma MIF levels and cardiac function and prognosis in patients with acute ST-segment elevation myocardial infarction (STEMI) with or without diabetes mellitus. Overall, 204 patients with STEMI who underwent emergency percutaneous coronary intervention were enrolled: 57 and 147 patients in the diabetes and nondiabetes STEMI groups, respectively. Sixty-five healthy people were selected as controls. Plasma MIF levels were measured at the time of diagnosis. Basic clinical data and echocardiographic findings within 72 h of admission were collected. Patients were followed up, and echocardiograms were reviewed at the 12-month follow-up. Plasma MIF levels were significantly higher in the diabetes and nondiabetes STEMI groups than in the control group and in patients with Killip grade≥II STEMI than in those with Killip grade I. Plasma MIF levels were negatively correlated with the left ventricular ejection fraction (LVEF) of myocardial infarction in patients with or without diabetes in the acute phase of infarction, whereas the left ventricular diastolic dysfunction (LVDD) was positively correlated. MIF levels in the nondiabetes STEMI group were positively correlated with N-terminal pro-b-type natriuretic peptide levels and were associated with LVEF and LVDD at the 12-month follow-up. The risk of adverse cardiovascular and cerebrovascular events was significantly higher in the MIF high-level group (≥52.7 ng/mL) than in the nondiabetes STEMI group 36 months after presentation. Thus, MIF levels in STEMI patients with or without diabetes can reflect acute cardiac function. In STEMI patients without diabetes, MIF levels can also indicate cardiac function and long-term prognosis at the 12-month follow-up.
format Article
id doaj-art-c835d10cd1344335b31b82131ae38c00
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-c835d10cd1344335b31b82131ae38c002025-08-20T02:19:41ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/82761808276180Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with DiabetesHaiyi Yu0Xinyu Wang1Xiangning Deng2Youyi Zhang3Wei Gao4Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, ChinaDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, ChinaDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, ChinaDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, ChinaDepartment of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, ChinaMacrophage migration inhibitory factor (MIF), a widely expressed pleiotropic cytokine, is reportedly involved in several cardiovascular diseases, in addition to inflammatory diseases. Plasma MIF levels are elevated in the early phase of acute cardiac infarction. This study is aimed at investigating the correlation between plasma MIF levels and cardiac function and prognosis in patients with acute ST-segment elevation myocardial infarction (STEMI) with or without diabetes mellitus. Overall, 204 patients with STEMI who underwent emergency percutaneous coronary intervention were enrolled: 57 and 147 patients in the diabetes and nondiabetes STEMI groups, respectively. Sixty-five healthy people were selected as controls. Plasma MIF levels were measured at the time of diagnosis. Basic clinical data and echocardiographic findings within 72 h of admission were collected. Patients were followed up, and echocardiograms were reviewed at the 12-month follow-up. Plasma MIF levels were significantly higher in the diabetes and nondiabetes STEMI groups than in the control group and in patients with Killip grade≥II STEMI than in those with Killip grade I. Plasma MIF levels were negatively correlated with the left ventricular ejection fraction (LVEF) of myocardial infarction in patients with or without diabetes in the acute phase of infarction, whereas the left ventricular diastolic dysfunction (LVDD) was positively correlated. MIF levels in the nondiabetes STEMI group were positively correlated with N-terminal pro-b-type natriuretic peptide levels and were associated with LVEF and LVDD at the 12-month follow-up. The risk of adverse cardiovascular and cerebrovascular events was significantly higher in the MIF high-level group (≥52.7 ng/mL) than in the nondiabetes STEMI group 36 months after presentation. Thus, MIF levels in STEMI patients with or without diabetes can reflect acute cardiac function. In STEMI patients without diabetes, MIF levels can also indicate cardiac function and long-term prognosis at the 12-month follow-up.http://dx.doi.org/10.1155/2019/8276180
spellingShingle Haiyi Yu
Xinyu Wang
Xiangning Deng
Youyi Zhang
Wei Gao
Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
Mediators of Inflammation
title Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
title_full Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
title_fullStr Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
title_full_unstemmed Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
title_short Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
title_sort correlation between plasma macrophage migration inhibitory factor levels and long term prognosis in patients with acute myocardial infarction complicated with diabetes
url http://dx.doi.org/10.1155/2019/8276180
work_keys_str_mv AT haiyiyu correlationbetweenplasmamacrophagemigrationinhibitoryfactorlevelsandlongtermprognosisinpatientswithacutemyocardialinfarctioncomplicatedwithdiabetes
AT xinyuwang correlationbetweenplasmamacrophagemigrationinhibitoryfactorlevelsandlongtermprognosisinpatientswithacutemyocardialinfarctioncomplicatedwithdiabetes
AT xiangningdeng correlationbetweenplasmamacrophagemigrationinhibitoryfactorlevelsandlongtermprognosisinpatientswithacutemyocardialinfarctioncomplicatedwithdiabetes
AT youyizhang correlationbetweenplasmamacrophagemigrationinhibitoryfactorlevelsandlongtermprognosisinpatientswithacutemyocardialinfarctioncomplicatedwithdiabetes
AT weigao correlationbetweenplasmamacrophagemigrationinhibitoryfactorlevelsandlongtermprognosisinpatientswithacutemyocardialinfarctioncomplicatedwithdiabetes